Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin in Werner Syndrome

NCT05847179 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Werner Syndrome

Interventions

DRUG: Progerinin

Sponsor

PRG Science & Technology Co., Ltd.